INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,045 | +19.7% | 81 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,709 | +23.8% | 81 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,381 | -12.5% | 81 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,579 | -21.0% | 81 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $2,000 | 0.0% | 81 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $2,000 | 0.0% | 81 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,000 | 0.0% | 81 | +15.7% | 0.00% | 0.0% |
| Q4 2021 | $2,000 | 0.0% | 70 | -7.9% | 0.00% | 0.0% |
| Q3 2021 | $2,000 | 0.0% | 76 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $2,000 | -33.3% | 76 | -9.5% | 0.00% | -50.0% |
| Q1 2021 | $3,000 | -25.0% | 84 | -11.6% | 0.00% | 0.0% |
| Q4 2020 | $4,000 | +100.0% | 95 | +41.8% | 0.00% | +100.0% |
| Q3 2020 | $2,000 | 0.0% | 67 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $2,000 | +100.0% | 67 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $1,000 | – | 67 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |